GYRE Competitors & Alternatives
Compare Gyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
GYRE
Main Stock$6.34
Tradestie Score
56
Market Cap
$688.47M
Revenue Growth
0.0%
Analyst Upside
+194.4%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$11.85
|
$757.72M | - | 58 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$33.64
|
$748.90M | - | 60 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$16.90
|
$726.21M | 7.6 | 52 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$22.71
|
$718.62M | - | 61 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$32.67
|
$715.25M | - | 61 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$146.03
|
$699.30M | - | 61 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.10
|
$670.30M | - | 48 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$12.34
|
$665.30M | - | 59 | Compare |
More GYRE Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry